These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 33824698)

  • 1. Alleviation of Inflammation and Oxidative Stress in Pressure Overload-Induced Cardiac Remodeling and Heart Failure via IL-6/STAT3 Inhibition by Raloxifene.
    Huo S; Shi W; Ma H; Yan D; Luo P; Guo J; Li C; Lin J; Zhang C; Li S; Lv J; Lin L
    Oxid Med Cell Longev; 2021; 2021():6699054. PubMed ID: 33824698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction.
    Zhao L; Cheng G; Jin R; Afzal MR; Samanta A; Xuan YT; Girgis M; Elias HK; Zhu Y; Davani A; Yang Y; Chen X; Ye S; Wang OL; Chen L; Hauptman J; Vincent RJ; Dawn B
    Circ Res; 2016 Jun; 118(12):1918-1929. PubMed ID: 27126808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eicosapentaenoic acid suppresses adverse effects of C-reactive protein overexpression on pressure overload-induced cardiac remodeling.
    Nagai T; Anzai T; Mano Y; Kaneko H; Anzai A; Sugano Y; Maekawa Y; Takahashi T; Yoshikawa T; Fukuda K
    Heart Vessels; 2013 May; 28(3):404-11. PubMed ID: 22875408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of estrogen, an ERα agonist and raloxifene on pressure overload induced cardiac hypertrophy.
    Westphal C; Schubert C; Prelle K; Penkalla A; Fliegner D; Petrov G; Regitz-Zagrosek V
    PLoS One; 2012; 7(12):e50802. PubMed ID: 23227210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB.
    Verma SK; Krishnamurthy P; Barefield D; Singh N; Gupta R; Lambers E; Thal M; Mackie A; Hoxha E; Ramirez V; Qin G; Sadayappan S; Ghosh AK; Kishore R
    Circulation; 2012 Jul; 126(4):418-29. PubMed ID: 22705886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy.
    Ma S; Feng J; Lin X; Liu J; Tang Y; Nie S; Gong J; Wang L
    Oxid Med Cell Longev; 2021; 2021():5546867. PubMed ID: 34567409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term but not long-term high fat diet feeding protects against pressure overload-induced heart failure through activation of mitophagy.
    Tan Y; Li M; Wu G; Lou J; Feng M; Xu J; Zhou J; Zhang P; Yang H; Dong L; Li J; Zhang X; Gao F
    Life Sci; 2021 May; 272():119242. PubMed ID: 33607155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Interleukin-6/glycoprotein 130 signalling by Bazedoxifene ameliorates cardiac remodelling in pressure overload mice.
    Shi W; Ma H; Liu T; Yan D; Luo P; Zhai M; Tao J; Huo S; Guo J; Li C; Lin J; Zhang C; Li S; Lv J; Lin L
    J Cell Mol Med; 2020 Apr; 24(8):4748-4761. PubMed ID: 32164044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The disruption of invariant natural killer T cells exacerbates cardiac hypertrophy and failure caused by pressure overload in mice.
    Takahashi M; Kinugawa S; Takada S; Kakutani N; Furihata T; Sobirin MA; Fukushima A; Obata Y; Saito A; Ishimori N; Iwabuchi K; Tsutsui H
    Exp Physiol; 2020 Mar; 105(3):489-501. PubMed ID: 31957919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Inhibition of NLRP3 Inflammasome Reverses Pressure Overload-Induced Pathological Cardiac Remodeling by Attenuating Hypertrophy, Fibrosis, and Inflammation.
    Zhao M; Zhang J; Xu Y; Liu J; Ye J; Wang Z; Ye D; Feng Y; Xu S; Pan W; Wang M; Wan J
    Int Immunopharmacol; 2021 Oct; 99():108046. PubMed ID: 34435581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cadherin-11-Interleukin-6 Signaling between Cardiac Fibroblast and Cardiomyocyte Promotes Ventricular Remodeling in a Mouse Pressure Overload-Induced Heart Failure Model.
    Fang G; Li Y; Yuan J; Cao W; Song S; Chen L; Wang Y; Wang Q
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure.
    Beak JY; Kang HS; Huang W; Myers PH; Bowles DE; Jetten AM; Jensen BC
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H186-H200. PubMed ID: 30387679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Anti-Inflammatory Mediator 17(R)-Resolvin D1 Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis.
    Wang M; Pan W; Wei C; Liu J; Zhang J; Yu J; Zhao M; Xu S; Ye J; Wang Z; Ye D; Feng Y; Xu Y; Wan J
    Drug Des Devel Ther; 2023; 17():3073-3083. PubMed ID: 37849783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin protects against the pathological cardiac hypertrophy induced by transverse aortic constriction through activating PGC-1β: In vivo and in vitro studies.
    Zhai M; Liu Z; Zhang B; Jing L; Li B; Li K; Chen X; Zhang M; Yu B; Ren K; Yang Y; Yi W; Yang J; Liu J; Yi D; Liang H; Jin Z; Reiter RJ; Duan W; Yu S
    J Pineal Res; 2017 Oct; 63(3):. PubMed ID: 28708271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SENP1 Protects Against Pressure Overload-Induced Cardiac Remodeling and Dysfunction Via Inhibiting STAT3 Signaling.
    Yang D; Fan D; Guo Z; Liu FY; Wang MY; An P; Yang Z; Tang QZ
    J Am Heart Assoc; 2022 Nov; 11(22):e027004. PubMed ID: 36370010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein overexpression exacerbates pressure overload-induced cardiac remodeling through enhanced inflammatory response.
    Nagai T; Anzai T; Kaneko H; Mano Y; Anzai A; Maekawa Y; Takahashi T; Meguro T; Yoshikawa T; Fukuda K
    Hypertension; 2011 Feb; 57(2):208-15. PubMed ID: 21220701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
    Pozios I; Seel NN; Hering NA; Hartmann L; Liu V; Camaj P; Müller MH; Lee LD; Bruns CJ; Kreis ME; Seeliger H
    Cell Oncol (Dordr); 2021 Feb; 44(1):167-177. PubMed ID: 32940862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raloxifene inhibits IL-6/STAT3 signaling pathway and protects against high-fat-induced atherosclerosis in ApoE
    Luo P; Shi W; Wang Y; Ma H; Liu T; Yan D; Huo S; Guo J; Wang M; Li C; Lin J; Zhang C; Li S; Lv J; Lin L
    Life Sci; 2020 Nov; 261():118304. PubMed ID: 32828944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
    Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
    Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosolic DNA sensor cGAS plays an essential pathogenetic role in pressure overload-induced heart failure.
    Hu D; Cui YX; Wu MY; Li L; Su LN; Lian Z; Chen H
    Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1525-H1537. PubMed ID: 32383996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.